02Jan 2018
FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION.
- University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.
- Keywords
- References
- Cite This Article as
- Corresponding Author
- Kee Y, D?Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia.J Clin Invest.2012;122:3799?3806.
- Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia.?2002;297(5581):606?609.
- Alter BP. Cancer in Fanconi anemia, 1927-2001. 2003; 15;97:425-440.
[Alparslan Merdin. (2018); FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION. Int. J. of Adv. Res. 6 (Jan). 36] (ISSN 2320-5407). www.journalijar.com
AlparslanMerdin
University of Health Sciences,Ankara Dr. Abdurrahman YurtaslanOncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.
University of Health Sciences,Ankara Dr. Abdurrahman YurtaslanOncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.